Live Events

To enable the learner to expand upon knowledge of blood disorders and to increase competency to practice sound clinical decision making, as derived from evidence-based education, standardized guidelines, case study evaluation, and methods intended to raise nursing care quality for persons with blood disorders treated within the federally recognized U.S. Hemophilia Treatment Center (HTC) Network

Upon completion of this learning activity, you will be able to:

• Discuss clinical presentation, laboratory evaluation, diagnosis, and treatment of rare blood disorders including von Willebrand disease (VWD), rare bleeding disorders, thrombosis/thrombophilia, and platelet disorders
• Utilize accessible information and data on treatment products and protocols in clinical management of rare bleeding disorders
• Analyze common clinical scenarios involving persons with rare blood disorders
• Develop a professional network of nurses from U.S. hemophilia treatment centers to enhance patient care and optimize outcomes

Nurses and nurse practitioners who currently are, and have been practicing for at least 2 years in the U.S. Hemophilia Treatment Center Network, and wish to gain knowledge and competence of blood disorders diagnosis and management

The University of Nebraska Medical Center College of Nursing Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

To attend this program, you must meet the following criteria:

• Be employed at a U.S. federally funded HTC as a nurse, nurse practitioner, physician assistant, or similar role for at least 2 years.
• Obtain approval to attend from Regional Coordinator via automated process upon submission of application.

There is no registration fee to attend Advanced Nursing Topics II.

Funding to support the Partners in Bleeding Disorders Education Program is provided through an unrestricted educational grant from Shire. The Partners in Bleeding Disorders Education Program: Advanced Nursing Topics I is supported by an educational grant from Genentech. Travel and lodging for program participants are made possible by an at-will contribution from the Indiana Hemophilia and Thrombosis Center./p>

Once registered, you will be contacted approximately 4 weeks before the program with instructions on scheduling your flight or rental car.
All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.

• January 25-26, 2021

Apply Now

To enhance the ability of the Hemophilia Treatment Center physical therapist to clinically evaluate and assess persons with hemophilia using evidence-based methodology in a family-centered care environment.

Upon completion of this learning activity, you will be able to:

• Describe four generations of recombinant products on the basis of the presence of human/animal proteins and albumin in the production process
• Differentiate joint health outcomes associated with prophylactic versus episodic treatment regimens
• Create a patient-specific physical therapy plan of care modeled on the World Health Organization's (WHO's) International Classification of Functioning, Disability, and Health (ICF)
• Interpret the subjective and objective elements of the National Hemophilia Foundation’s Physical Therapy Examination Practice Guidelines
• Accurately administer the Hemophilia Joint Health Score (HJHS) as one component of the physical therapy assessment given a patient with hemophilia
• Summarize the current evidence on the use of POC MSKUS for the evaluation of markers of disease activity and of degenerative changes in patients with hemophilia
• Demonstrate familiarity with previously unclear concepts pertaining to physical therapy management of bleeding disorders
• Explain the role that the injury recovery course may play in the ability of a patient with hemophilia to resume normal activity
• List two surgical and two nonsurgical interventions that may be utilized in a patient with hemophilic arthropathy

Physical therapists who are employed full- or part-time in the federally recognized U.S. Hemophilia Treatment Center Network and treat patients with bleeding disorders and wish to expand their clinical decision-making and patient evaluation and assessment skills beyond the introductory level of the Basic Partners Program.

This conference is pending ProCert Continuing Competence Certification.
ProCert is a comprehensive continuing competence activity certification program developed by the Federation of State Board of Physical Therapy (FSBPT) as directed by its members - the 53 U.S. jurisdiction physical therapy licensing boards ("jurisdiction boards").
Please note not all states recognize ProCert. Click here to see if your jurisdiction accepts continuing competence activities certified by ProCert.
If your state does not recognize ProCert and you wish to submit program information to your state's Board, you are welcome to contact us for supporting documentation to assist with your submission. However, due to budgetary and personnel restraints, Partners does not make state-specific CEU submissions or cover costs associated with those submissions.

To attend this program, you must meet the following criteria:

• Employment within the federally-recognized U.S. Hemophilia Treatment Center Network
• Approval from Regional Coordinator (via automated process upon submission of application)
• Completion of no-cost prerequisite:
• Registration and download of the Hemophilia Joint Health Score (HJHS) manual, summary score, and worksheet from the International Prophylaxis Group Study website, www.IPSG.ca.*
  *Note: You must register and receive approval to access the site. The approval process can take a few days. Please allow ample time to complete this task prior to the conference.

There is no registration fee to attend attend Advanced Partners for Physical Therapists.

The Partners in Bleeding Disorders Education Program is supported by an unrestricted educational grant from Shire. Attendee travel and accommodations are covered for by an at-will contribution from the Indiana Hemophilia & Thrombosis Center (IHTC). Once registered, you will be contacted approximately 4 weeks before the program with instructions on scheduling your flight or rental car.
All registrants are encouraged to read the Partners Travel Policy to understand costs that are covered and costs that you may incur.

• September 30-October 2, 2021

Apply Now